Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

New treatments for alopecia areata focus on targeting immune responses for better results.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Transplant success has improved with better immunosuppressive drugs and donor matching.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Transplant patients often get skin problems, with treatments varying by condition.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document says to treat cat fungal infections with medicine and clean the environment, noting that cats without symptoms can still spread it to humans.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.